Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial

BACKGROUND: Obesity is strongly associated with prevalence of obstructive sleep apnea (OSA), and weight loss has been shown to reduce disease severity. OBJECTIVE: To investigate whether liraglutide 3.0 mg reduces OSA severity compared with placebo using the primary end point of change in apnea–hypop...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackman, A, Foster, G D, Zammit, G, Rosenberg, R, Aronne, L, Wadden, T, Claudius, B, Jensen, C B, Mignot, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973216/
https://www.ncbi.nlm.nih.gov/pubmed/27005405
http://dx.doi.org/10.1038/ijo.2016.52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973216/
https://www.ncbi.nlm.nih.gov/pubmed/27005405
http://dx.doi.org/10.1038/ijo.2016.52

Ejemplares similares